glp-1 research papers The Clinical Trial Landscape in 2024 GLP-1 meds may not offset
Description
The burden of CKD resulting from T2D, quantified with disability and mortality risk measures, has increased since 1990, mostly due to population expansion and ageing [2]
Heart 72 , S46S51 (1994)
10.1261/rna.7202705 RNA 23 Huang daW.ShermanB
, Furigo, I
Endocrinol Metab (Seoul), 29:567-573
Aust Dent J
